可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Holmes DR, Detre KM, Williams DO, et al. Longterm outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry[J]. Circulation, 1993,87:21-29.
[2] Maiello L, Colombo A, Gianrossi R, et al. Survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction[J]. Chest, 1994,105:733-740.
[3] Reynen K, Kunkel B, Gansser R, et al. Percutaneous transluminal coronary angioplasty in patients with severely depressed function[J]. Cardiology, 1993, 83:358-366.
[4] Shihara M, Tsutsui H, Tsuchihashi M, et al . Inhospital and one year outcomes for patients undergoing percutaneous coronary Intervention for acute myocardial infarction[J]. Am J Cardiol, 2002, 90 (9): 932-936.
[5] Anonymous. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators[J]. N Engl J Med, 1992,327:685-691.
[6] Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction.Results of the survival and ventricular enlargement trial[J]. N Engl J Med, 1992,327:669-677.